Improving Tolerance of Treatment of Pulmonary MAC Infections

Mycobacterium avium complex infection

Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF Patients RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease Phase 2a Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM) Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections Improving Tolerance of Treatment of Pulmonary MAC Infections Early Bactericidal Activity of Standard Drugs Used to Treat Mycobacterium Avium Complex: a Pilot Study Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)